IDEAS home Printed from https://ideas.repec.org/r/rff/dpaper/dp-06-19.html
   My bibliography  Save this item

Adjusting the Value of a Statistical Life for Age and Cohort Effects

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Hala Abou-Ali & Hesham El-Azony & Heba El-Laithy & Jonathan Haughton & Shahid Khandker, 2010. "Evaluating the impact of Egyptian Social Fund for Development programmes," Journal of Development Effectiveness, Taylor & Francis Journals, vol. 2(4), pages 521-555.
  2. James K. Hammitt & Jin-Tan Liu & Jin-Long Liu, 2022. "Is survival a luxury good? Income elasticity of the value per statistical life," Journal of Risk and Uncertainty, Springer, vol. 65(3), pages 239-260, December.
  3. Ray C. Fair & Christopher Champa, 2019. "Estimated Costs of Injuries in College and High School Female Sports," Cowles Foundation Discussion Papers 2188, Cowles Foundation for Research in Economics, Yale University.
  4. Thomas J. Kniesner & W. Kip Viscusi, 2023. "Compensating Differentials for Occupational Health and Safety Risks: Implications of Recent Evidence," Research in Labor Economics, in: 50th Celebratory Volume, volume 50, pages 83-116, Emerald Group Publishing Limited.
  5. Hammitt, James K., 2023. "Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year," TSE Working Papers 23-1431, Toulouse School of Economics (TSE).
  6. Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2017. "Medical progress, demand for health care, and economic performance," ECON WPS - Working Papers in Economic Theory and Policy 08/2017, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
  7. Antoine Bommier & Bertrand Villeneuve, 2012. "Risk Aversion and the Value of Risk to Life," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 79(1), pages 77-104, March.
  8. Thomas Kniesner & W. Viscusi & James Ziliak, 2010. "Policy relevant heterogeneity in the value of statistical life: New evidence from panel data quantile regressions," Journal of Risk and Uncertainty, Springer, vol. 40(1), pages 15-31, February.
  9. Joseph E. Aldy & W. Kip Viscusi, 2007. "Age Differences in the Value of Statistical Life: Revealed Preference Evidence," Review of Environmental Economics and Policy, Association of Environmental and Resource Economists, vol. 1(2), pages 241-260, Summer.
  10. Herrera-Araujo, Daniel & Rochaix, Lise, 2020. "Does the Value per Statistical Life vary with age or baseline health? Evidence from a compensating wage study in France," Journal of Environmental Economics and Management, Elsevier, vol. 103(C).
  11. Ivan Frankovic & Michael Kuhn & Stefan Wrzaczek, 2016. "Medical Care within an OLG Economy with Realistic Demography," VID Working Papers 1603, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna.
  12. Hostenkamp, Gisela & Lichtenberg, Frank R., 2015. "The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence," Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
  13. Lisa A. Robinson & James K. Hammitt, 2016. "Valuing Reductions in Fatal Illness Risks: Implications of Recent Research," Health Economics, John Wiley & Sons, Ltd., vol. 25(8), pages 1039-1052, August.
  14. James K. Hammitt & Peter Morfeld & Jouni T. Tuomisto & Thomas C. Erren, 2020. "Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks," Risk Analysis, John Wiley & Sons, vol. 40(4), pages 674-695, April.
  15. Hammitt, James K. & Herrera-Araujo, Daniel, 2018. "Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys," Journal of Environmental Economics and Management, Elsevier, vol. 87(C), pages 165-189.
  16. The Untold Standards of Living Story: The GDP value of Twentieth Century Health Improvements in Developed Economies, 2012. "Hickson, Kerry," CAGE Online Working Paper Series 105, Competitive Advantage in the Global Economy (CAGE).
  17. Henry A. Roman & James K. Hammitt & Tyra L. Walsh & David M. Stieb, 2012. "Expert Elicitation of the Value per Statistical Life in an Air Pollution Context," Risk Analysis, John Wiley & Sons, vol. 32(12), pages 2133-2151, December.
  18. Ketcham, Jonathan & Kuminoff, Nicolai & Saha, Nirman, 2023. "Valuing Statistical Life Using Seniors' Medical Spending," RFF Working Paper Series 23-16, Resources for the Future.
  19. James K. Hammitt, 2020. "Valuing mortality risk in the time of COVID-19," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 129-154, October.
  20. Agamoni Majumder & S. Madheswaran, 2017. "Meta-analysis of Value of Statistical Life Estimates," IIM Kozhikode Society & Management Review, , vol. 6(1), pages 110-120, January.
  21. Lichtenberg, Frank R., 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009," Economics & Human Biology, Elsevier, vol. 13(C), pages 107-127.
  22. Ivan Frankovic & Michael Kuhn & Stefan Wrzaczek, 2020. "On the Anatomy of Medical Progress Within an Overlapping Generations Economy," De Economist, Springer, vol. 168(2), pages 215-257, June.
  23. Je-Liang Liou, 2019. "Effect of Income Heterogeneity on Valuation of Mortality Risk in Taiwan: An Application of Unconditional Quantile Regression Method," IJERPH, MDPI, vol. 16(9), pages 1-15, May.
  24. James K. Hammitt & Tuba Tunçel, 2023. "Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve," Journal of Risk and Uncertainty, Springer, vol. 67(3), pages 239-269, December.
  25. Patrick Carlin & Brian E. Dixon & Kosali I. Simon & Ryan Sullivan & Coady Wing, 2022. "How Undervalued is the Covid-19 Vaccine? Evidence from Discrete Choice Experiments and VSL Benchmarks," NBER Working Papers 30118, National Bureau of Economic Research, Inc.
  26. Laura Armey & Thomas J. Kniesner & John D. Leeth & Ryan Sullivan, 2022. "Combat, casualties, and compensation: Evidence from Iraq and Afghanistan," Contemporary Economic Policy, Western Economic Association International, vol. 40(1), pages 66-82, January.
  27. Jytte Nielsen & Susan Chilton & Michael Jones-Lee & Hugh Metcalf, 2010. "How would you like your gain in life expectancy to be provided? An experimental approach," Journal of Risk and Uncertainty, Springer, vol. 41(3), pages 195-218, December.
  28. James K. Hammitt, 2017. "Valuing Non-Fatal Health Risks: Monetary and Health-Utility Measures," Revue économique, Presses de Sciences-Po, vol. 68(3), pages 335-356.
  29. Thomas DeLeire & Shakeeb Khan & Christopher Timmins, 2013. "Roy Model Sorting And Nonrandom Selection In The Valuation Of A Statistical Life," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 54(1), pages 279-306, February.
  30. Mary F. Evans & V. Kerry Smith, 2022. "Complementary and the measurement of Individual Risk Tradeoffs: Accounting for Quantity and Quality of Life Effects," Chapters, in: The Economics of Environmental Risk, chapter 5, pages 77-96, Edward Elgar Publishing.
  31. Agamoni Majumder & S. Madheswaran, 2017. "Compensating wage differential and value of statistical life: a meta-analysis," The Indian Journal of Labour Economics, Springer;The Indian Society of Labour Economics (ISLE), vol. 60(4), pages 527-548, December.
  32. Richards-Shubik, Seth & Roberts, Mark S. & Donohue, Julie M., 2022. "Measuring quality effects in equilibrium," Journal of Health Economics, Elsevier, vol. 83(C).
  33. Seidu Dauda & Abe C. Dunn & Anne E. Hall, 2019. "Are Medical Care Prices Still Declining? A Systematic Examination of Quality-Adjusted Price Index Alternatives for Medical Care," BEA Working Papers 0166, Bureau of Economic Analysis.
  34. David Boisclair & Yann Décarie & François Laliberté-Auger & Pierre-Carl Michaud & Carole Vincent, 2018. "The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-13, January.
  35. Ray C. Fair & Christopher Champa, 2019. "Estimated Costs of Contact in College and High School Male Sports," Journal of Sports Economics, , vol. 20(5), pages 690-717, June.
  36. Martin Gaynor & Nirav Mehta & Seth Richards-Shubik, 2020. "Optimal Contracting with Altruistic Agents: A Structural Model of Medicare Payments for Dialysis Drugs," NBER Working Papers 27172, National Bureau of Economic Research, Inc.
  37. Robert J. Brent, 2023. "Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare," IJERPH, MDPI, vol. 20(5), pages 1-12, March.
  38. Borgschulte, Mark & Vogler, Jacob, 2020. "Did the ACA Medicaid expansion save lives?," Journal of Health Economics, Elsevier, vol. 72(C).
  39. Svensson, Mikael, 2006. "The Value of a Statistical Life in Sweden Estimates from Two Studies using the "Certainty Approach" Calibration," Working Papers 2006:6, Örebro University, School of Business, revised 12 May 2009.
  40. Andersson, Henrik, 2006. "Willingness to Pay for Road Safety and Estimates of the Risk of Death: Evidence from a Swedish Contingent Valuation Study," Working Papers 2006:5, Swedish National Road & Transport Research Institute (VTI).
  41. Kochi Ikuho & Taylor Laura O, 2011. "Risk Heterogeneity and the Value of Reducing Fatal Risks: Further Market-Based Evidence," Journal of Benefit-Cost Analysis, De Gruyter, vol. 2(3), pages 1-28, August.
  42. Rheinberger, Christoph M. & Hammitt, James K., 2014. "The welfare value of FDA's mercury-in-fish advisory: A dynamic reanalysis," Journal of Health Economics, Elsevier, vol. 37(C), pages 113-122.
  43. W. Kip Viscusi, 2020. "Pricing the global health risks of the COVID-19 pandemic," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 101-128, October.
  44. Agamoni Majumder & S. Madheswaran, 2020. "Compensation for Occupational Risk and Valuation of Statistical Life," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 149(3), pages 967-989, June.
  45. Petek, Nathan, 2022. "The marginal benefit of hospitals: Evidence from the effect of entry and exit on utilization and mortality rates," Journal of Health Economics, Elsevier, vol. 86(C).
  46. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
  47. Dauda, Seidu & Dunn, Abe & Hall, Anne, 2022. "A systematic examination of quality-adjusted price index alternatives for medical care using claims data," Journal of Health Economics, Elsevier, vol. 85(C).
  48. Parry, Ian W.H. & Laxminarayan, Ramanan & West, Sarah E., 2006. "Fiscal and Externality Rationales for Alcohol Taxes," RFF Working Paper Series dp-06-51, Resources for the Future.
  49. James K. Hammitt, 2023. "Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year," Health Economics, John Wiley & Sons, Ltd., vol. 32(9), pages 1964-1981, September.
  50. Chandra Amitabh & MacEwan Joanna P. & Campinha-Bacote Avrita & Khan Zeba M., 2016. "Returns to Society from Investment in Cancer Research and Development," Forum for Health Economics & Policy, De Gruyter, vol. 19(1), pages 71-86, June.
  51. James Hammitt & Kevin Haninger, 2010. "Valuing fatal risks to children and adults: Effects of disease, latency, and risk aversion," Journal of Risk and Uncertainty, Springer, vol. 40(1), pages 57-83, February.
  52. Ryan Edwards, 2013. "The cost of uncertain life span," Journal of Population Economics, Springer;European Society for Population Economics, vol. 26(4), pages 1485-1522, October.
  53. Brajer, Victor & Mead, Robert W. & Xiao, Feng, 2008. "Health benefits of tunneling through the Chinese environmental Kuznets curve (EKC)," Ecological Economics, Elsevier, vol. 66(4), pages 674-686, July.
  54. Damien Sheehan-Connor & Theodore Bergstrom & Rodney Garratt, 2015. "Saving lives with stem cell transplants," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 23-51, August.
  55. Hammitt, James K. & Tuncel, Tuba, 2023. "Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve," TSE Working Papers 23-1416, Toulouse School of Economics (TSE).
  56. Kniesner, Thomas J. & Viscusi, W. Kip, 2023. "Promoting Equity through Equitable Risk Tradeoffs," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 14(1), pages 8-34, March.
  57. Aldy, Joseph E. & Smyth, Seamus J., 2014. "Heterogeneity in the Value of Life," RFF Working Paper Series dp-14-13, Resources for the Future.
  58. Thomas J. Kniesner & W. Kip Viscusi & Christopher Woock & James P. Ziliak, 2012. "The Value of a Statistical Life: Evidence from Panel Data," The Review of Economics and Statistics, MIT Press, vol. 94(1), pages 74-87, February.
  59. Hua Zan & Robert L. Scharff, 2017. "Regional Differences in the Value of Statistical Life," Journal of Consumer Policy, Springer, vol. 40(2), pages 157-176, June.
  60. Cem Tekeşin & Shihomi Ara, 2014. "Measuring the Value of Mortality Risk Reductions in Turkey," IJERPH, MDPI, vol. 11(7), pages 1-33, July.
  61. Aldy, Joseph, 2019. "Birds of a Feather: Estimating the Value of Statistical Life from Dual-Earner Families," Working Paper Series rwp19-013, Harvard University, John F. Kennedy School of Government.
  62. Kerry Hickson, 2014. "The GDP Value of Twentieth-Century Health Improvements in Developed Economies: Initial Estimates for England," Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 60(2), pages 385-399, June.
  63. Ray C. Fair & Christopher Champa, 2017. "Estimated Costs of Contact in College and High School Male Sports," Cowles Foundation Discussion Papers 2101R, Cowles Foundation for Research in Economics, Yale University, revised Oct 2017.
  64. Amitabh Chandra & Jonathan Skinner, 2012. "Technology Growth and Expenditure Growth in Health Care," Journal of Economic Literature, American Economic Association, vol. 50(3), pages 645-680, September.
  65. Hammitt, James K., 2020. "Accounting for the distribution of benefits & costs in benefit-cost analysis," TSE Working Papers 20-1116, Toulouse School of Economics (TSE).
  66. Swensen, Isaac D., 2015. "Substance-abuse treatment and mortality," Journal of Public Economics, Elsevier, vol. 122(C), pages 13-30.
  67. W. Viscusi, 2008. "How to value a life," Journal of Economics and Finance, Springer;Academy of Economics and Finance, vol. 32(4), pages 311-323, October.
  68. Cameron, Trudy Ann & DeShazo, J.R., 2013. "Demand for health risk reductions," Journal of Environmental Economics and Management, Elsevier, vol. 65(1), pages 87-109.
  69. Joseph E. Aldy, 2019. "Birds of a feather: Estimating the value of statistical life from dual-earner families," Journal of Risk and Uncertainty, Springer, vol. 58(2), pages 187-205, June.
  70. W. Kip Viscusi, 2015. "The Role of Publication Selection Bias in Estimates of the Value of a Statistical Life," American Journal of Health Economics, University of Chicago Press, vol. 1(1), pages 27-52, Winter.
  71. Engy Ziedan & Kosali I. Simon & Coady Wing, 2022. "Mortality Effects of Healthcare Supply Shocks: Evidence Using Linked Deaths and Electronic Health Records," NBER Working Papers 30553, National Bureau of Economic Research, Inc.
  72. Meera Kotagal & Kiran J Agarwal-Harding & Charles Mock & Robert Quansah & Carlos Arreola-Risa & John G Meara, 2014. "Health and Economic Benefits of Improved Injury Prevention and Trauma Care Worldwide," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-7, March.
  73. Lisa A. Robinson & James K. Hammitt, 2015. "Research Synthesis and the Value per Statistical Life," Risk Analysis, John Wiley & Sons, vol. 35(6), pages 1086-1100, June.
  74. James O’Brien, 2018. "Age, autos, and the value of a statistical life," Journal of Risk and Uncertainty, Springer, vol. 57(1), pages 51-79, August.
  75. Balmford, Ben & Bateman, Ian J. & Bolt, Katherine & Day, Brett & Ferrini, Silvia, 2019. "The value of statistical life for adults and children: Comparisons of the contingent valuation and chained approaches," Resource and Energy Economics, Elsevier, vol. 57(C), pages 68-84.
  76. Frank R. Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 277-299, July.
  77. Martin Lauren & Lotspeich Richard, 2014. "A benefit-cost framework for early intervention to prevent sex trading," Journal of Benefit-Cost Analysis, De Gruyter, vol. 5(1), pages 1-45, January.
  78. Gao, Xuwen & Song, Ran & Timmins, Christopher, 2023. "Information, migration, and the value of clean air," Journal of Development Economics, Elsevier, vol. 163(C).
  79. Ray C. Fair & Christopher Champa, 2017. "Estimated Costs of Contact in Men's Collegiate Sports," Cowles Foundation Discussion Papers 2101, Cowles Foundation for Research in Economics, Yale University.
  80. Robert J. Johnston & Kevin J. Boyle & Maria L. Loureiro & Ståle Navrud & John Rolfe, 2021. "Guidance to Enhance the Validity and Credibility of Environmental Benefit Transfers," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 79(3), pages 575-624, July.
  81. Moreno Gigi & van Eijndhoven Emma & Benner Jennifer & Sullivan Jeffrey, 2017. "The Long-Term Impact of Price Controls in Medicare Part D," Forum for Health Economics & Policy, De Gruyter, vol. 20(2), pages 1-56, December.
  82. Ray C. Fair & Christopher Champa, 2017. "Estimated Costs of Contact in Men's Collegiate Sports," Cowles Foundation Discussion Papers 3001, Cowles Foundation for Research in Economics, Yale University.
  83. Nadia J. Sweis, 2022. "Revisiting the value of a statistical life: an international approach during COVID-19," Risk Management, Palgrave Macmillan, vol. 24(3), pages 259-272, September.
  84. Lichtenberg, Frank R. & Tatar, Mehtap & Çalışkan, Zafer, 2014. "The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010," Health Policy, Elsevier, vol. 117(3), pages 361-373.
  85. Blake C Alkire & Jeffrey R Vincent & Christy Turlington Burns & Ian S Metzler & Paul E Farmer & John G Meara, 2012. "Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-10, April.
  86. Clapp, John M. & Eichholtz, Piet & Lindenthal, Thies, 2013. "Real option value over a housing market cycle," Regional Science and Urban Economics, Elsevier, vol. 43(6), pages 862-874.
  87. Benjamin A. Jones, 2017. "The social costs of uranium mining in the US Colorado Plateau cohort, 1960–2005," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 62(4), pages 471-478, May.
  88. Jessica Carrick-Hagenbarth & Eric Edlund & Avanti Mukherjee, 2023. "Analysis of Hybrid Epidemiological-Economic Models of COVID-19 Mitigation Policies," Eastern Economic Journal, Palgrave Macmillan;Eastern Economic Association, vol. 49(4), pages 585-612, October.
  89. W. Kip Viscusi, 2009. "The devaluation of life," Regulation & Governance, John Wiley & Sons, vol. 3(2), pages 103-127, June.
  90. Anna Scherbina, 2021. "Assessing the Optimality of a COVID Lockdown in the United States," Economics of Disasters and Climate Change, Springer, vol. 5(2), pages 177-201, July.
  91. Pretnar, Nick, 2020. "The Intergenerational Welfare Implications of Disease Contagion," MPRA Paper 101862, University Library of Munich, Germany, revised 14 Jul 2020.
  92. Frank Lichtenberg, 2015. "The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010," Applied Health Economics and Health Policy, Springer, vol. 13(2), pages 207-222, April.
  93. Nicolò Gatti & Beatrice Retali, 2021. "Fighting the spread of Covid-19 : was the Swiss lockdown worth it?," IdEP Economic Papers 2101, USI Università della Svizzera italiana.
  94. Cropper, Maureen L. & Joiner, Emily & Krupnick, Alan, 2023. "Revisiting the Environmental Protection Agency's Value of a Statistical Life," RFF Working Paper Series 23-30, Resources for the Future.
  95. Zahran, Sammy & Iverson, Terrence & McElmurry, Shawn P. & Weiler, Stephan & Levitt, Ryan, 2019. "Hidden Costs of Blight and Arson in Detroit: Evidence From a Natural Experiment in Devil's Night," Ecological Economics, Elsevier, vol. 157(C), pages 266-277.
  96. van Benthem, Arthur, 2015. "What is the optimal speed limit on freeways?," Journal of Public Economics, Elsevier, vol. 124(C), pages 44-62.
  97. Martin Gaynor & Nirav Mehta & Seth Richards-Shubik, 2023. "Optimal Contracting with Altruistic Agents: Medicare Payments for Dialysis Drugs," American Economic Review, American Economic Association, vol. 113(6), pages 1530-1571, June.
  98. Churchill, Brandyn F., 2021. "How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC's HPV vaccine requirement," Journal of Health Economics, Elsevier, vol. 78(C).
  99. Enrico Miglino & Nicolás Navarrete H. & Gonzalo Navarrete H. & Pablo Navarrete H., 2023. "Health Effects of Increasing Income for the Elderly: Evidence from a Chilean Pension Program," American Economic Journal: Economic Policy, American Economic Association, vol. 15(1), pages 370-393, February.
  100. James Hammitt & Tuba Tunçel, 2015. "Preferences for life-expectancy gains: Sooner or later?," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 79-101, August.
  101. Nicolò Gatti & Beatrice Retali, 2021. "Saving lives during the COVID-19 pandemic: the benefits of the first Swiss lockdown," Swiss Journal of Economics and Statistics, Springer;Swiss Society of Economics and Statistics, vol. 157(1), pages 1-21, December.
  102. W. Viscusi & Elissa Gentry, 2015. "The value of a statistical life for transportation regulations: A test of the benefits transfer methodology," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 53-77, August.
  103. W. Kip Viscusi, 2018. "Pricing Lives: International Guideposts for Safety," The Economic Record, The Economic Society of Australia, vol. 94(S1), pages 1-10, June.
  104. Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
  105. Trudy Cameron & J. DeShazo & Peter Stiffler, 2010. "Demand for health risk reductions: A cross-national comparison between the U.S. and Canada," Journal of Risk and Uncertainty, Springer, vol. 41(3), pages 245-273, December.
  106. Sugiarto, Wisnu, 2022. "The Impact of Wildlife Crossing Structures on Wildlife-Vehicle Collisions," 2022 Annual Meeting, July 31-August 2, Anaheim, California 322205, Agricultural and Applied Economics Association.
  107. Zhang, Nan & Mendelsohn, Robert & Shaw, Daigee, 2023. "How to Identify and Estimate the Demand for Job Safety?," MPRA Paper 118594, University Library of Munich, Germany.
  108. Restrepo, Brandon J. & Rieger, Matthias, 2016. "Trans fat and cardiovascular disease mortality: Evidence from bans in restaurants in New York," Journal of Health Economics, Elsevier, vol. 45(C), pages 176-196.
  109. Michael Jones-Lee & Susan Chilton & Hugh Metcalf & Jytte Nielsen, 2015. "Valuing gains in life expectancy: Clarifying some ambiguities," Journal of Risk and Uncertainty, Springer, vol. 51(1), pages 1-21, August.
  110. James Hammitt, 2013. "Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures," Journal of Risk and Uncertainty, Springer, vol. 47(3), pages 311-325, December.
  111. Herrera, Gabriel Paes & Constantino, Michel & Su, Jen-Je & Naranpanawa, Athula, 2023. "The use of ICTs and income distribution in Brazil: A machine learning explanation using SHAP values," Telecommunications Policy, Elsevier, vol. 47(8).
  112. Gentry, Elissa Philip & Viscusi, W. Kip, 2016. "The fatality and morbidity components of the value of statistical life," Journal of Health Economics, Elsevier, vol. 46(C), pages 90-99.
  113. Stephen C. Newbold, 2011. "Valuing Health Risk Changes Using a Life-Cycle Consumption Framework," NCEE Working Paper Series 201103, National Center for Environmental Economics, U.S. Environmental Protection Agency, revised Apr 2011.
  114. Julien Hugonnier & Florian Pelgrin & Pascal St-Amour, 2010. "A structural analysis of the health expenditures and portfolio choices of retired agents," Swiss Finance Institute Research Paper Series 10-29, Swiss Finance Institute.
  115. Joseph E. Aldy, 2019. "Birds of a Feather: Estimating the Value of Statistical Life from Dual-Earner Families," NBER Working Papers 25708, National Bureau of Economic Research, Inc.
  116. Ray C. Fair & Christopher Champa, 2017. "Estimated Costs of Contact in College and High School Male Sports," Cowles Foundation Discussion Papers 3001R, Cowles Foundation for Research in Economics, Yale University, revised Oct 2017.
  117. Luciana Echazu & Diego C. Nocetti, 2020. "Willingness to pay for morbidity and mortality risk reductions during an epidemic. Theory and preliminary evidence from COVID-19," The Geneva Risk and Insurance Review, Palgrave Macmillan;International Association for the Study of Insurance Economics (The Geneva Association), vol. 45(2), pages 114-133, September.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.